Company: SINT
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021930
Chunk: 4

Company: Sintx Technologies, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 8
Chunk 4
---

had not been fully operational since the acquisition of the armor equipment in July 2021 and had been completely shut down since October
2023.

As
discussed in Note 2 to the condensed consolidated financial statements, on February 19, 2025, the Company sold to Tethon all the issued
and outstanding shares of TA&T in exchange for the assumption by Tethon of the outstanding liabilities of TA&T.

As
discussed in further detail above, in October 2025, the Company received FDA 510(k) clearance for
a new foot and ankle osteotomy wedge system, enabling SINTX’s commercial entry into reconstructive foot and ankle surgery in the
United States. Revenue is expected to begin during the first half of 2026.

As
discussed in Note 14 to the condensed consolidated financial statements, in October 2025, the Company entered into the 2025 ATM Agreement
to sell shares of its common stock from time to time, through an “at the market offering” program, having an aggregate offering
price of $6,413,876 was filed with the SEC.

As
discussed in Note 12 to the condensed consolidated financial statements, in October 2025, the Company entered into a sublease agreement
to lease the SINTX armor facility, that is expected to save the Company approximately $950,000 over the sublease term.

The Company believes that based on its existing capital resources and funds generated by operations, there is no
significant uncertainty of the Company’s ability to continue as a going concern through at least November 12, 2026.

Recent
Accounting Pronouncements 

ASU
2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures

In
December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” on the topic
of income taxes. The standard requires additional disclosure for income taxes. These requirements include: (i) requiring a public entity
to disclose specific categories in the rate reconciliation; (ii) disclosure of additional information for reconciling items that meet
a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying
pretax income or loss by the applicable statutory income tax rate); (iii) annual disclosure of the amount of income taxes paid (net of
refunds received) disaggregated